Wealth Enhancement Advisory Services
XERS icon

Wealth Enhancement Advisory Services’s Xeris Biopharma Holdings XERS Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$127K Sell
26,758
-4,496
-14% -$21.4K ﹤0.01% 3072
2025
Q1 		$172K Buy
31,254
+14,986
+92% +$82.3K ﹤0.01% 2639
2024
Q4 		$55.1K Buy
16,268
+3,847
+31% +$13K ﹤0.01% 2821
2024
Q3 		$35.4K Buy
+12,421
New +$35.4K ﹤0.01% 2581